Skip GNB
Skip Content
About Us
Company
Our DNA
Fact Sheet
Milestones
Leadership
Key Executives
CEO Message
Location
Headquarters
Samsung Biologics America
Useful Pages
Virtual Exhibition Hall
Plant 4 Showroom
Facilities - 360° Tour
Our Services
Development Services
Overview
Cell Line Development
Process Development
Performance
Clinical Manufacturing
Manufacturing Services
Overview
Drug Substance
- Mammalian
- mRNA
Drug Product
Quality
Overview
Quality Assurance
Quality Control
Biosafety Testing Services
Analytical Testing Services
Careers
Our Values
Working With Us
Career Development
Benefits
Diversity & Inclusion
How to Apply
Application Process
OverseasExperienced
LocalExperienced
NewHiresULevel
NewHiresCLevel
Intern
FAQs
Job Information
Sustainability
ESG Management
Our Commitment
Resources
Environmental
Climate Actions
SHE Management
Environment
Safety
Health
Social
Human Rights
Compliance
Business Ethics
Corporate Social Responsibility
BCMS
Governance
Articles of Incorporation
Board Structure
BOD Committees
Corporate Governance
External Auditor
Investor Relations
Overview
Financial Information
Financial Snapshot
Public Disclosures
Audited
Financial Statements
Annual/Business Report
Earnings Release
Stock & Shareholder
Information
Listing Information
Stock Charts
Ownership Structure
General Meeting of Shareholders
IR Resource
IR Notice
Newsroom
Newsroom
Company News
Press Release
News Brief
Media Focus
Our Story
Life @ Samsung Biologics
Samsung Bio Insight
Science & Technology
Whitepapers
Posters
Webinars
Events
PR Materials
Brochures & Infographics
Company Images
Videos
CLIENT PORTAL
KOR
ENG
Selectd
search
NEWSFEED
Contact Us
Client Portal
mobile menu button
Search Close
Enter a search term
home
CONTACT US
IR Notice
Notice
2022 Closing Announcement of FY2022
March 17, 2023
LINKEDIN
FACEBOOK